Krishna Institute of Medical Sciences Limited
KIMS
Rank in Stocks
#4756
Krishna Institute of Medical Sciences Limited, known by its brand KIMS... Krishna Institute of Medical Sciences Limited, known by its brand KIMS Hospitals across India, delivers a broad spectrum of medical and healthcare services. The institution boasts a comprehensive array of specialized fields, including cardiology, dentistry, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgeries. Additionally, it offers expertise in gastroenterology, hepatology, heart and lung transplantation, general organ transplantation, maternal and pediatric care. Other key areas of focus include emergency and accident services, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, Alzheimer's care, and dedicated bone and joint centers. Founded in 1973, the company is headquartered in Secunderabad, India.
Share Price
$7.49
Last synced: 2026-10-19
Market Cap
$3.14B
Change (1 day)
-0.99%
Change (1 year)
-8.59%
Country
IN
Trade Krishna Institute of Medical Sciences Limited (KIMS)
Category
Healthcare
Dividend history for Krishna Institute of Medical Sciences Limited (KIMS)
Krishna Institute of Medical Sciences Limited (stock symbol: KIMS) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Krishna Institute of Medical Sciences Limited (KIMS) from 2026 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 35.00% |
US
|
|
| 0.00% |
DE
|
|
| 49.00% |
US
|
|
| 23.00% |
SA
|
|
| 19.00% |
BR
|